Wordt geladen...
Combination systemic therapies with immune checkpoint inhibitors in pancreatic cancer: overcoming resistance to single-agent checkpoint blockade
Immune checkpoint inhibitors have demonstrated broad single-agent antitumor activity and a favorable safety profile that render them attractive agents to combine with other systemic anticancer therapies. Pancreatic cancer has been fairly resistant to monotherapy blockade of programmed cell death pro...
Bewaard in:
| Gepubliceerd in: | Clin Transl Med |
|---|---|
| Hoofdauteurs: | , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer Berlin Heidelberg
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6174117/ https://ncbi.nlm.nih.gov/pubmed/30294755 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40169-018-0210-9 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|